CD14 Is Involved in the Interferon Response of Human Macrophages to Rubella Virus Infection

Erik Schilling1, Lukas Pfeiffer2, Sunna Hauschildt3,4

  • 1Institute of Clinical Immunology, Medical Faculty, Leipzig University, Johannisallee 30, 04103 Leipzig, Germany.

Biomedicines
|February 25, 2022
PubMed

Insights

Rubella virus (RuV) infection reduces CD14 expression in M2 macrophages, impacting the innate immune response. Blocking CD14 enhances RuV replication and lowers interferon production, suggesting a role in virus adaptation.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Macrophages (MΦ) are key immune cells involved in rubella virus (RuV) pathogenesis.
  • Understanding RuV interaction with the innate immune system is crucial.

Purpose of the Study:

  • To investigate the role of CD14 in MΦ during RuV infection.
  • To elucidate the impact of CD14 modulation on innate immune responses to RuV.

Main Methods:

  • Comparing RuV replication kinetics in M1-like (GM-MΦ) and M2-like (M-MΦ) macrophages.
  • Assessing CD14 expression changes post-RuV infection and exogenous interferon-beta (IFN-β) treatment.
  • Utilizing anti-CD14 blocking antibodies to study CD14's contribution to cytokine/chemokine generation during RuV infection.

Main Results:

  • RuV infection, particularly in M-MΦ, reduced CD14 expression.
  • Exogenous IFN-β mimicked RuV's effect on glycolytic reserve but not CD14 expression.
  • Blocking CD14 enhanced RuV progeny generation and significantly reduced IFN expression.

Conclusions:

  • Downmodulation of CD14 during RuV infection of M-MΦ contributes to virus-host adaptation.
  • Reduced CD14 expression is linked to a diminished IFN response, facilitating viral persistence.